VAROKIBART
UNII HO08KW5LSB

Substance Identification & Data

This profile provides standardized clinical and technical data for Varokibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HO08KW5LSB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2643349-04-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

HO08KW5LSB

CAS Registry Number

2643349-04-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VAROKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190452

National Cancer Institute reference terminology for clinical and research data.

INN ID

12309

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Varokibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VAROKIBART

Common Names & Synonyms

GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-443) (VH (HOMO SAPIENS IGHV4-31*02 (99%) -(IGHD) -IGHJ5*01 (93.8%)) (10.7.9)(26-35.53-59.98-106) (1-117) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, G4V5 H P10, G4V21 CH2 Y15.1, T16, E18 (CH1 (118-215), HINGE 1-12 S10>P (225) (216-227), CH2 L92 (312), M>Y15.1 (249), S>T16 (251), T>E18 (253) (228-337), CH3 (338-442), CHS K2>DEL (443)) (118-443)), (131-213')-DISULFIDE WITH LAMBDA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-LAMBDA (HOMO SAPIENS IGLV1-21*02 (94.8%) -IGLJ2*01 (100%)) (6.3.11) (26-31.49-51.88-98) (1'-108')-HOMO SAPIENS IGLC2*01(100%) (109'-214')); DIMER(223-223'':226-226'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1SV, GLYCOFORM ALFA

IMMUNOGLOBULIN G4 (225-PROLINE,249-TYROSINE,251-THREONINE,253-GLUTAMIC ACID,DE-444-LYSINE), ANTI-(HUMAN INTERLEUKIN 5) (HUMAN CLONE 3A5.046 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN CLONE 3A5.046 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G4 (225-PROLINE,249-TYROSINE,251-THREONINE,253-GLUTAMIC ACID,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN INTERLEUKIN 5) (HUMAN MONOCLONAL TEV-53275 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TEV-53275 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-LAMBDA, ANTI-(HOMO SAPIENS IL5 (INTERLEUKIN 5, IL-5)), HOMO SAPIENS MONOCLONAL ANTIBODY

VAROKIBART [INN]